Workshops

 

Pre-Annual Meeting Workshops Day 1
Saturday, June 20

 

Full Day Sessions

WS01: Introduction to Ethics in Health Technology Assessment
08:30-16:30

The relevance and importance of incorporating ethical analysis into HTA is increasingly acknowledged. This course is developed for international participants to learn about and apply methods that can be used to explore potential ethical implications of health technology. Sessions will highlight how to adapt approaches in ethics for all types of health technologies and across international settings.

WS02: HTA 102 – Hospital Based HTA
08:30 – 16:30

Hospitals are globally starting to produce hospital based HTA (HB-HTA) and to use HB-HTA as the basis for decision making. This workshop will give the participants skills to produce high quality HB-HTAs in their local hospitals on the basis of evidence from the AdHopHTA project and provide an understanding of how HB-HTA can be organized, produced and implemented at hospitals.

 

Morning Sessions

WS03: High Quality Registry Data; A Workshop On Quality Standards That Should Be Expected For International Collaboration In HTA
08:30 – 12:00

This workshop will present REQueST®, the first ‘standardised tool’ for quality assessment of registries for regulatory and HTA purposes. The audience will simulate a review of up to 5 clinical registries (regional, national, and international) with a range of purposes (scientific, clinical, policy). The workshop will finish with a discussion of the tool’s appropriateness and usability for the intended audience.

WS04 Evidence Synthesis In HTA: From Pairwise To Network Meta-Analysis
08:30 – 12:00

This workshop will explore the principles and practices of conducting pairwise and network meta-analysis through a mixture of presentations and exercises using MetaInsight. Participants will learn about the whole process from formulating appropriate research questions, through the conduct of meta-analysis to the interpretation of results, as well as gain an in-depth understanding of the issues regarding evidence synthesis for HTA.

WS05: Immunotherapy – Standardization, Adaptation, and Transparency in Health Technology Assessment
08:30 – 12:00

Immunotherapy substantially improves patient outcomes, but presents many challenges for health technology assessment (HTA), including survival extrapolation, comparative effectiveness, etc. This workshop will present novel methods to address these challenges, and approaches to implement these methods in a standardized and transparent manner. It will also present considerations for model adaptations from the HTA perspectives in different countries/regions.

WS06: Evaluation of Artificial Intelligence in Medicine
08:30 – 12:00

The medical industry is an aggregation of sectors that provides goods and services to treat patients. Artificial intelligence could be used to optimize resources allocation of medical industry given limited medical resources. Nowadays, artificial intelligence in medicine faces a massive challenge in promoting the application smoothly. In this workshop, we discuss how to evaluate artificial intelligence in medicine.

WS07: HTA 101 – Introduction to Health Technology Assessment
08:30 – 12:00

This popular workshop is updated and offered at all HTAi annual meetings. It provides an understanding of important HTA concepts, methods, current issues, and trends to help attendees to engage fully in the annual meeting. It is good for both those who are new to HTA and those who want a “refresher” course. The course leader is Clifford Goodman, PhD, a past president of HTAi.

 

Afternoon Sessions

WS08: Boost Your Value Assessment By Correctly Using The Underrated Force Of PROs – 5 Simple Steps To Success
13:00 – 16:30

Despite the importance of patient-reported outcomes (PRO) for a patient-centered assessment, results from PROs are regularly subject to denial by HTA bodies. Workshop participants will learn about the validation of PROs, the reasons for rejection with the help of German value assessments, and simple measures which can improve the acceptance of PRO results in every HTA country.

WS09: Yea or Nay? Making Coverage Decisions for Disruptive Therapies
13:00 – 16:30

Disruptive therapies provide incomparable therapeutic benefits, but often at a high cost. Harnessing innovation while controlling drug spending is one of the most challenging tasks in ensuring the sustainability of healthcare systems. This workshop will use case studies to explore issues surrounding evidence requirements and coverage decision-making frameworks when applied to disruptive therapies.

WS10: Horizon Scanning Of Innovative Health Technologies For HTA Stakeholders
13:00 – 16:30

This workshop will cover developing horizon scanning (HS) processes, from discovery and monitoring, to elimination and early notification to HTA bodies. It will include:

Participants will gain the knowledge to develop a robust, transparent and efficient HS system.

WS11: HTA To Support Sustainable UHC: A Shared Experience
13:00 – 16:30

Central to the global goal of Universal Health Coverage (UHC), is access to essential medicines and health products. HTA is a critical tool in order to make such access sustainable. This workshop provides an overview of the global public goods and services provided by WHO and provides a forum for workshop attendees to share experience.

WS16: Research Directions and Publishing in HTA – The IJTAHC for HTA & HTAi
13:00 – 16:30

This workshop will provide attendees and the IJTAHC editors an opportunity to discuss anticipated regulatory policy developments that impact HTA; and identify gaps within the literature, that if addressed, would support assessments of future health technologies.

Attendees will be asked to participate in round-table discussions and a mapping exercise, which will help form the focus of upcoming Journal editions.

 

PRE-ANNUAL MEETING WORKSHOPS DAY 2:
SUNDAY, JUNE 16 

 

Full Day Sessions 

WS12: Value Assessment of Medical Devices: VBHC & HTA Around the World
8:30 – 16:30

This workshop will be conducted by the newly formed Medical Devices Interest Group from HTAi.  It will focus on the value assessment of medical devices, HTA, value-based healthcare, and focus on key geographies including Europe, LMIC and AsiaPacific regions.  There will be a dedicated session on value assessment and HTA in China.

WS13: Identify Possible Steps to Improve Patient Involvement in HTA By Applying Patient Involvement Frameworks and High-Level Gap Analysis
8:30 – 16:30

This workshop seeks to identify gaps and potential improvements in patient involvement in HTA. Participants will learn about patient involvement practices in different HTA stages and systems. Participants will actively apply techniques to identify gaps and potential opportunities for patient involvement in specific HTA settings. Workshop insights will support strengthening patient voices in critical decisions for sustaining Universal Health Coverage.

 

Morning Sessions

WS14: How To Establish Your Horizon Scanning System For Disinvestment Of Low Added Value Technologies
8:30 – 12:00

A joint initiative between HTAi IG on DEA, EuroScan and the IG on ethics and hospital Based HTA was aimed to design and elaborate a toolkit to those that had the objective to establish a disinvestment system in their organizations, hospitals, regions or nations. The workshops will be practical and describing the different steps to make it possible.

WS15: The Use Of Evidence-Informed Deliberative Processes For HTA In Low And Middle Income Countries
8:30 – 12:00

On their path towards universal health coverage, low and middle income countries (LMIC) need to make choices in the design of national HTA processes, in terms of scoping, assessment, appraisal and communication & appeal. This workshop provides guidance on how to make these choices, informed by the theory of evidence-informed deliberative processes (EDPs), international best practices and examples from LMIC.

WS17: Generating and Using Real World Evidence for Health Technology Assessment
8:30 – 12:00

The Regulatory Interactions and Conditional Coverage (RICC) interest group will deliver this workshop with an aim to provide a basic understanding on how real world evidence is generated and used for health technology assessment, especially in managed entry agreements.

 

Afternoon Sessions

WS18: VALIDATE – A New EU-Funded Long-Distance Learning Course On HTA As A Specific Type Of Policy Analysis
13:00 – 16:30

HTA is widely seen as a specific type of policy-research. However, in its course of development it has failed to take account of crucially important insights from policy sciences. The VALIDATE (VALues In Doing Assessments of healthcare TEchnologies) project aims to redress this and offers an e-learning course, an accompanying handbook, and appropriate opportunities for internships at European HTA Agencies.

WS19: Conceptualizing Patient-Involvement in Countries with Expanding Healthcare Coverage: Identifying Opportunities in Low- and Middle-Income Countries
13:00 – 16:30

The aim of this workshop is to conceptualize Patient and Public Involvement (PPI) and to outline approaches on how to drive PPI in countries with expanding healthcare coverage. After exploring examples of Patient and Public Involvement (PPI) in Low- and Middle-Income countries (LMIC), the participants will interactively elaborate the determinants for PPI and specific requirements in the LMIC context.

WS20: What Does Good Look Like? Evaluating Decision-Grade Real-World Evidence (RWE)
13:00 – 16:30

The goal of HTA decision-making is to determine treatment effectiveness in clinical practice; however, RCTs – the primary evidence in appraisals – have limited generalizability. RWE can bridge this efficacy-effectiveness gap. The workshop will focus on what makes RWE “decision-grade” and will incorporate these concepts into a comparative effectiveness study evaluation on an analytics platform.

WS21: Making HTA Easier: Discretely-Integrated Condition Event (DICE) Simulation for Modeling
13:00 – 16:30

DICE-simulation is at the core of the EU-supported IMPACT-HTA Grant because it provides a simple yet powerful way to implement health-economic models. The workshop introduces the concepts and provides the skills to design, build, validate, review and use DICE.